Mark J. Daniel
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Mark J. Daniel
Mark J. Daniel is recorded as CFO at Atossa Therapeutics, Inc. (ATOS). The proxy statement of Atossa Therapeutics, Inc. reports total compensation of $536,489 for Mark J. Daniel in fiscal 2025, including a base salary of $72,516.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Atossa Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Steven Quay CEO
- Greg Weaver CFO
- Mark Daniel CFO, Chief Accounting Officer
- Dr. Tessa Cigler, M.D., M.P.H. Board Member
- H. Lawrence Remmel, Esq. Board Member
- Jonathan Finn Board Member
- Jonathan Finn, CFA Board Member
- Shu-Chih Chen Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Atossa Therapeutics, Inc. (ATOS) | — | $72,516 | $536,489 |
Recent activity
No call appearances or filed executive changes recorded yet.